Hematology & Oncology in Chesapeake, VA
6 verified hematology & oncology doctors in Chesapeake.
Hematologist-oncologists treat blood disorders and cancers, coordinating chemotherapy and blood-related care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Craig Franzman, MD
Hematology & Oncology
CMS Open Payments· $112.21 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$112.21
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Craig Franzman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. William Maclaughlin, MD
Hematology & Oncology
CMS Open Payments· $6,774 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6,774
Total received
5
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 79th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to William Maclaughlin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. William Clark, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Amy Skorupa, MD
Hematology & Oncology
CMS Open Payments· $366.29 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$366.29
Total received
8
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 58th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Amy Skorupa do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Cristina Alencar, MD
Hematology & Oncology
CMS Open Payments· $10,980 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$10,980
Total received
7
Transactions
2
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 81th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Cristina Alencar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michail Alevizakos, MD
Hematology & Oncology
CMS Open Payments· $123.88 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$123.88
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Michail Alevizakos do not imply any wrongdoing. Many are meals, education, or research support.